Warner Bros. Discovery, Inc.
[1,2,4]triazolo[1,5-c]pyrimidine derivative as A.sub.2A receptor inhibitor
Last updated:
Abstract:
Provided are a compound represented by formula (I), an isomer or a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to A.sub.2A receptor. The R.sub.1, R.sub.2, R.sub.3, ring A, ring B, n, and m are as defined in the specification. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
8 Apr 2018
Issue date:
14 Sep 2021